Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
about
The role of general nuclear medicine in breast cancerSuperparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude miceBone metastasis risk factors in breast cancer.Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer.Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.
P2860
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@en
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@nl
type
label
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@en
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@nl
prefLabel
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@en
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@nl
P2093
P2860
P1476
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
@en
P2093
Liang-qian Tong
Shan-feng Guo
Sheng Zhou
Xiao-hua Zhu
Xiu-zhen Xie
Zhi-qun Xianyu
P2860
P304
P356
10.1007/S11596-013-1083-1
P577
2013-02-08T00:00:00Z